FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897550493> ?p ?o ?g. }

• W2897550493 abstract "Abstract Aseptic loosening due to wear particle‐induced osteolysis is the main cause of arthroplasty failure and the influence of postmenopausal osteoporosis and anti‐osteoporosis treatment on Titanium (Ti) particle‐induced osteolysis remains unclear. 66 C57BL/6J female mice were used in this study. Ovariectomy (OVX) was performed to induce osteopenia mice and confirmed by micro‐CT. The Ti particle‐induced mouse calvaria osteolysis model was established subsequently and both OVX and Sham‐OVX mice were divided into four groups, respectively: Ti (‐) group, Ti group, Ti + zoledronic acid (ZOL) group (50ug/kg, local administration, single dose) and Ti + teriparatide (TPTD) group (40ug/kg/d, subcutaneous injection*14d). Mice calvarias were collected for micro‐CT and histomorphometric analysis 2 weeks after particle induction. 8 weeks after bilateral OVX, significantly reduced BMD and microstructure parameters in both proximal tibia and calvaria were observed in OVX mice when comparing with Sham‐OVX mice. OVX mice in Ti group had not only markly decreased BMD and BV/TV, but also significantly increased total porosity, eroded surface area and osteoclast numbers when comparing with Sham‐OVX mice. Shown by Two‐way ANOVA analysis, the interaction terms between OVX and Ti implantation on micro‐CT and histomorphometry parameters didn’t reach significant difference. As illustrated by micro‐CT and histological analysis, ZOL treatment markedly inhibited Ti particle‐induced osteolysis in OVX mice and Sham‐OVX mice, and there were significant differences when comparing to both Ti and Ti+TPTD group. The combination of osteoporosis and Ti particle implantation result in aggravated bone resorption, accompanied with increased osteoclasts and excessive inflammation response. ZOL was more effective in preventing Ti particle‐induced osteolysis in both OVX mice and Sham‐OVX mice than TPTD in short‐term administration. ZOL exert the protective effects on Ti particle‐induced bone loss via the suppression of osteoclasts." @default.
• W2897550493 created "2018-10-26" @default.
• W2897550493 creator A5009743341 @default.
• W2897550493 creator A5033171381 @default.
• W2897550493 creator A5050268277 @default.
• W2897550493 creator A5058060985 @default.
• W2897550493 creator A5061332222 @default.
• W2897550493 creator A5062112479 @default.
• W2897550493 creator A5074030815 @default.
• W2897550493 creator A5078209767 @default.
• W2897550493 creator A5086264545 @default.
• W2897550493 creator A5090739340 @default.
• W2897550493 date "2018-09-01" @default.
• W2897550493 modified "2023-10-18" @default.
• W2897550493 title "Antiresorptive Agents are More Effective in Preventing Titanium Particle-Induced Calvarial Osteolysis in Ovariectomized Mice Than Anabolic Agents in Short-Term Administration" @default.
• W2897550493 cites W12084434 @default.
• W2897550493 cites W13052883 @default.
• W2897550493 cites W1513192165 @default.
• W2897550493 cites W1529166900 @default.
• W2897550493 cites W1615018155 @default.
• W2897550493 cites W1689035515 @default.
• W2897550493 cites W1777836280 @default.
• W2897550493 cites W1891153992 @default.
• W2897550493 cites W1902527964 @default.
• W2897550493 cites W1966448542 @default.
• W2897550493 cites W1978585175 @default.
• W2897550493 cites W1980063187 @default.
• W2897550493 cites W1980808291 @default.
• W2897550493 cites W1989856795 @default.
• W2897550493 cites W1994071585 @default.
• W2897550493 cites W1999559229 @default.
• W2897550493 cites W2001363791 @default.
• W2897550493 cites W2005876513 @default.
• W2897550493 cites W2005968626 @default.
• W2897550493 cites W2008083304 @default.
• W2897550493 cites W2010976912 @default.
• W2897550493 cites W2020852091 @default.
• W2897550493 cites W2025343005 @default.
• W2897550493 cites W2026914049 @default.
• W2897550493 cites W2027496373 @default.
• W2897550493 cites W2034003234 @default.
• W2897550493 cites W2047671092 @default.
• W2897550493 cites W2051855500 @default.
• W2897550493 cites W2059180322 @default.
• W2897550493 cites W2065324203 @default.
• W2897550493 cites W2066749771 @default.
• W2897550493 cites W2071284555 @default.
• W2897550493 cites W2072452605 @default.
• W2897550493 cites W2079078331 @default.
• W2897550493 cites W2087524048 @default.
• W2897550493 cites W2094343376 @default.
• W2897550493 cites W2096425957 @default.
• W2897550493 cites W2101775069 @default.
• W2897550493 cites W2132248607 @default.
• W2897550493 cites W2142042072 @default.
• W2897550493 cites W2143705716 @default.
• W2897550493 cites W2159329881 @default.
• W2897550493 cites W2176336088 @default.
• W2897550493 cites W2181056920 @default.
• W2897550493 cites W2214947554 @default.
• W2897550493 cites W2345797855 @default.
• W2897550493 cites W2403056245 @default.
• W2897550493 cites W2410645058 @default.
• W2897550493 cites W2411706165 @default.
• W2897550493 cites W2495479188 @default.
• W2897550493 cites W2514429472 @default.
• W2897550493 cites W2529535353 @default.
• W2897550493 cites W254601787 @default.
• W2897550493 cites W2619775926 @default.
• W2897550493 cites W2619941415 @default.
• W2897550493 doi "https://doi.org/10.1111/aor.13271" @default.
• W2897550493 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6585759" @default.
• W2897550493 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30328628" @default.
• W2897550493 hasPublicationYear "2018" @default.
• W2897550493 type Work @default.
• W2897550493 sameAs 2897550493 @default.
• W2897550493 citedByCount "10" @default.
• W2897550493 countsByYear W28975504932019 @default.
• W2897550493 countsByYear W28975504932020 @default.
• W2897550493 countsByYear W28975504932021 @default.
• W2897550493 countsByYear W28975504932022 @default.
• W2897550493 countsByYear W28975504932023 @default.
• W2897550493 crossrefType "journal-article" @default.
• W2897550493 hasAuthorship W2897550493A5009743341 @default.
• W2897550493 hasAuthorship W2897550493A5033171381 @default.
• W2897550493 hasAuthorship W2897550493A5050268277 @default.
• W2897550493 hasAuthorship W2897550493A5058060985 @default.
• W2897550493 hasAuthorship W2897550493A5061332222 @default.
• W2897550493 hasAuthorship W2897550493A5062112479 @default.
• W2897550493 hasAuthorship W2897550493A5074030815 @default.
• W2897550493 hasAuthorship W2897550493A5078209767 @default.
• W2897550493 hasAuthorship W2897550493A5086264545 @default.
• W2897550493 hasAuthorship W2897550493A5090739340 @default.
• W2897550493 hasBestOaLocation W28975504931 @default.
• W2897550493 hasConcept C126322002 @default.
• W2897550493 hasConcept C134018914 @default.
• W2897550493 hasConcept C170493617 @default.
• W2897550493 hasConcept C185592680 @default.
• W2897550493 hasConcept C199343813 @default.
• W2897550493 hasConcept C202751555 @default.

• next